Sonova Holding (OTCMKTS:SONVY) Receives Consensus Rating of “Hold” from Brokerages

Shares of Sonova Holding (OTCMKTS:SONVY) have been given a consensus recommendation of “Hold” by the eight analysts that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, one has assigned a buy recommendation and two have issued a strong buy recommendation on the company.

Several research analysts have recently commented on the stock. Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Citigroup reissued a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Finally, Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th.

Sonova Price Performance

Shares of SONVY opened at $51.92 on Wednesday. The firm has a 50-day simple moving average of $46.75 and a two-hundred day simple moving average of $49.90. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. Sonova has a 1-year low of $42.26 and a 1-year high of $63.69.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.